Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-Land 3S: Landiolol for tachyarrhythmia in sepsis
jRCT2080223711Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of landiolol in sepsis and tachyarrhythmia (2 arms), sponsored by Ono Pharmaceutical. Started Nov 2017; status: completed.
02
Drugs
landiolol
03
Conditions
sepsistachyarrhythmia
Beyond the preview
Go deeper on jRCT2080223711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223711.